STME Stimcell Energetics Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1493712 · Fiscal year ends 05/31
Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-4.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-2,067.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets3,334.9%
Debt / equity—
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.39x
Accruals ratio-1,257.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q1*2026-08-31 | 2026Q4*2026-05-31 | 2026Q3*2026-02-28 | 2026Q2*2025-11-30 | 2026Q1*2025-08-31 | 2025Q4*2025-05-31 | 2025Q3*2025-02-28 | 2025Q2*2024-11-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $67,296 | $71,270 | $8,208 | $163,598 | $139,484 | $141,473 | $32,847 | $22,681 |
| Interest expense | $22,960 | $20,740 | $18,658 | $16,702 | $13,248 | $11,143 | $9,451 | $8,810 |
| Net income | -$169,518 | -$229,459 | -$90,566 | -$309,748 | -$265,602 | -$219,329 | -$140,537 | -$139,508 |
| EPS (basic) | -0.01 | — | 0.00 | -0.01 | -0.01 | — | -0.01 | -0.01 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $6,883 | $3,057 | $10,257 | $46,159 | $6,437 | $14,581 | $6,678 | $33,821 |
| Total assets | $60,946 | $81,454 | $34,521 | $52,345 | $16,387 | $21,222 | $17,110 | $38,346 |
| Total liabilities | $2.03M | $1.89M | $1.71M | $1.59M | $1.41M | $1.27M | $1.09M | $1.02M |
| Shareholders' equity | -$1.97M | -$1.81M | -$1.68M | -$1.54M | -$1.39M | -$1.25M | -$1.07M | -$982,705 |
| Cash flow statement | ||||||||
| Operating cash flow | -$108,995 | -$43,511 | -$86,290 | -$74,138 | -$108,142 | -$58,448 | -$43,716 | -$16,519 |
| Financing cash flow | $112,826 | $36,334 | $50,000 | $114,248 | $100,000 | $66,113 | $16,745 | $30,000 |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.